Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Debate

Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities

Authors: Delia Boccia, Debora Pedrazzoli, Tom Wingfield, Ernesto Jaramillo, Knut Lönnroth, James Lewis, James Hargreaves, Carlton A. Evans

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Cash transfer interventions are forms of social protection based on the provision of cash to vulnerable households with the aim of reduce risk, vulnerability, chronic poverty and improve human capital. Such interventions are already an integral part of the response to HIV/AIDS in some settings and have recently been identified as a core element of World Health Organization’s End TB Strategy. However, limited impact evaluations and operational evidence are currently available to inform this policy transition.

Discussion

This paper aims to assist national tuberculosis (TB) programs with this new policy direction by providing them with an overview of concepts and definitions used in the social protection sector and by reviewing some of the most critical operational aspects associated with the implementation of cash transfer interventions. These include: 1) the various implementation models that can be used depending on the context and the public health goal of the intervention; 2) the main challenges associated with the use of conditionalities and how they influence the impact of cash transfer interventions on health-related outcomes; 3) the implication of targeting diseases-affected households and or individuals versus the general population; and 4) the financial sustainability of including health-related objectives within existing cash transfer programmes. We aimed to appraise these issues in the light of TB epidemiology, care and prevention. For our appraisal we draw extensively from the literature on cash transfers and build upon the lessons learnt so far from other health outcomes and mainly HIV/AIDS.

Conclusions

The implementation of cash transfer interventions in the context of TB is still hampered by important knowledge gaps. Initial directions can be certainly derived from the literature on cash transfers schemes and other public health challenges such as HIV/AIDS. However, the development of a solid research agenda to address persisting unknowns on the impact of cash transfers on TB epidemiology and control is vital to inform and support the adoption of the post-2015 End TB strategy.
Literature
1.
WHO. Global Tuberculosis Report 2015. Geneva: World Health Organization; 2015.
2.
Raviglione M, Zumla A, Marais B, Horton R, Motsoaledi A. A sustainable agenda for tuberculosis control and research. Lancet. 2012;379(9821):1077–8.CrossRefPubMed
3.
Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010–50: cure, care, and social development. Lancet. 2010;375(9728):1814–29.CrossRefPubMed
4.
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet. 2015;385(9979):1799–801.CrossRefPubMed
5.
Devereux S, Sabates-Wheeler R. Transformative social protection. IDS Working Paper N. 232. Brighton: Institute of Development Studies, University of Sussex; 2004.
6.
Fiszbein A, Schady N. Conditional cash transfers. Reducing present and future poverty. Washington DC: The World Bank; 2009.CrossRef
7.
World Bank. The state of social safety nets 2015. Washington, United States. 2015
8.
Lagarde M, Blaauw D. A review of the application and contribution of discrete choice experiments to inform human resources policy interventions. Hum Resour Health. 2009;7:62.CrossRefPubMedPubMedCentral
9.
Ranganathan M, Lagarde M. Promoting healthy behaviours and improving health outcomes in low and middle income countries: a review of the impact of conditional cash transfer programmes. Prev Med. 2012;55(Suppl):S95–105.CrossRefPubMed
10.
Lagarde M, Haines A, Palmer N. The impact of conditional cash transfers on health outcomes and use of health services in low and middle income countries. Cochrane Database Syst Rev. 2009;4:CD008137.PubMed
11.
Pettifor A, MacPhail C, Nguyen N, Rosenberg M. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16(7):1729–38.CrossRefPubMedPubMedCentral
12.
13.
UNDP. Cash Transfers and HIV prevention. Discussion paper. New York: United Nations Development Programme; 2014.
14.
Lim SS, Dandona L, Hoisington JA, Spencer LJ, Hogan MC, Gakidou E. India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: an impact evaluation. Lancet. 2010;375(9730):2009–23.CrossRefPubMed
15.
Boccia D, Hargreaves JR, Lonnroth K, Jaramillo E, Uplekar M, Porter JDH, et al. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis. 2011;15(Supplement 2):S37–49.CrossRefPubMedPubMedCentral
16.
Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101(4):654–62.CrossRefPubMedPubMedCentral
17.
18.
Richter LM, Lonnroth K, Desmond C, Jackson R, Jaramillo E, Weil D. Economic support to patients in HIV and TB grants in rounds 7 and 10 from the global fund to fight AIDS, tuberculosis and malaria. PLoS One. 2014;9(1):e86225.CrossRefPubMedPubMedCentral
19.
Bonell C, Oakley A, Hargreaves J, Strange V, Rees R. Assessment of generalisability in trials of health interventions: suggested framework and systematic review. BMJ. 2006;333(7563):346–9.CrossRefPubMedPubMedCentral
20.
Armstrong R, Waters E, Doyle J. Chapter 21: Systematic reviews in health promotion and public health interventions. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions Version 2 Available from wwwcochrane-handbookorg: The Cochrane Collaboration; 2008.
21.
Jackson N, Waters E. Criteria for the systematic review of health promotion and public health interventions. Health Promot Int. 2005;20(4):367–74.CrossRefPubMed
22.
23.
World Health Organization. Eliminating the catastrophic economic burden of TB: Universal Health Coverage and social protection opportunities. 29 April - 1 May 2013; Sao Paulo, Brazil.
24.
Gopalan SS, Mutasa R, Friedman J, Das A. Health sector demand-side financial incentives in low- and middle-income countries: a systematic review on demand- and supply-side effects. Soc Sci Med. 2014;100:72–83.CrossRefPubMed
25.
Lagarde M, Palmer N. The impact of contracting out on health outcomes and use of health services in low and middle-income countries. Cochrane Database Syst Rev. 2009;4:CD008133.PubMed
26.
Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379(9823):1320–9.CrossRefPubMed
27.
Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J. Incentives and enablers to improve adherence in tuberculosis. Cochrane Database Syst Rev. 2015;9:CD007952.PubMed
28.
Rocha C, Montoya R, Zevallos K, Curatola A, Ynga W, Franco J, et al. Innovative socioeconomic interventions against TB (ISIAT) – an operational assessment. Int J Tuberc Lung Dis. 2011;15(Supplement 2):S50–7.CrossRefPubMedPubMedCentral
29.
Torrens AW, Rasella D, Boccia D, Maciel EL, Nery JS, Olson ZD, et al. Effectiveness of a conditional cash transfer programme on TB cure rate: a retrospective cohort study in Brazil. Trans R Soc Trop Med Hyg. 2016;110(3):199–206.CrossRefPubMed
30.
Sripad A, Castedo J, Danford N, Zaha R, Freile C. Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18(1):44–8.CrossRefPubMed
31.
Ciobanu A, Domente L, Soltan V, Bivol S, Severin L, Plesca V, et al. Do incentives improve tuberculosis treatment outcomes in the Republic of Moldova? Public Health Action. 2014;4 Suppl 2:S59–63.CrossRefPubMedPubMedCentral
32.
Reeves A, Basu S, McKee M, Stuckler D, Sandgren A, Semenza J. Social protection and tuberculosis control in 21 European countries, 1995–2012: a cross-national statistical modelling analysis. Lancet Infect Dis. 2014;14(11):1105–12.CrossRefPubMed
33.
Siroka AP, N.A. Lönnroth, K. Association between spending on social protection and tuberculosis burden: a global multivariate regression analysis. Lancet Infect Dis. 2016;16(4):473–9.
34.
Baird S, McIntosh C, Ozler B. Cash or condition? Evidence from a cash transfer experiment. Q J Econ. 2011;126(4):1709–53.CrossRef
35.
Miller E, Samson M. HIV-sensitive social protection: state of the evidence in Sub-Saharan Africa. UNICEF and Economic Policy Research Institute, 2012
36.
37.
38.
Schüring E. Cashing in. How cash transfers shore up Zambian households affected by HIV. Berlin: German Technical Cooperation (GTZ); 2009.
39.
Schüring E, Boonstoppel E, Michelo S. Final evaluation report: Kalomo Social Cash Transfer Scheme. Lusaka: Ministry of Community Development and Social Services (MCDSS) and the German Technical Cooperation (GTZ); 2007.
40.
Whitworth A, Wright G, Noble M. A Review of Income Transfers to Disabled and Long Term Sick People in Seven Case Study Countries and Implications for South Africa. United Kingdom: Centre for the Analysis of South African Social Policy. Department of social policy and social work, University of Oxford; 2006.
41.
Soares TS. Bolsa Familia, its design, its impact and possibilities for the future. Working paper Number 89. Brazilia: International Policy Centre for Inclusive Growth; 2012.
42.
de Oliveira NF, Goncalves MJ. Social and environmental factors associated with the hospitalization of tuberculosis patients. Rev Lat Am Enfermagem. 2013;21(2):507–14.CrossRefPubMed
43.
Lutge E, Lewin S, Volmink J. Economic support to improve tuberculosis treatment outcomes in South Africa: a qualitative process evaluation of a cluster randomized controlled trial. Trials. 2014;15:236.CrossRefPubMedPubMedCentral
44.
Lutge E, Lewin S, Volmink J, Friedman I, Lombard C. Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial. Trials. 2013;14:154.CrossRefPubMedPubMedCentral
45.
Temin M. HIV-sensitive social protection: What does the evidence say? New York: UNICEF; 2010.
46.
Wingfield T, Boccia D, Tovar MA, Huff D, Montoya R, Lewis JJ, et al. Designing and implementing a socioeconomic intervention to enhance TB control: operational evidence from the CRESIPT project in Peru. BMC Public Health. 2015;15(1):810.CrossRefPubMedPubMedCentral
47.
Handa S, Halpern CT, Pettifor A, Thirumurthy H. The government of Kenya's cash transfer program reduces the risk of sexual debut among young people age 15–25. PLoS One. 2014;9(1):e85473.CrossRefPubMedPubMedCentral
48.
Adato M, Bassett L. What is the potential of cash transfers to strengthen families affected by HIV and AIDS? A review of the evidence on impacts and key policy debate. Joint learning initiative on children and HIV/AIDS JLICA. Washington, DC: Food Consumption and Nutrution Division. International Food Policy Research Institute; 2008.
49.
Gonzales-Flores M. Leaving the safety net: an analysis of dropouts in an urban conditional cash transfer program. World Dev. 2012;40(12):2505–21.CrossRef
50.
Schubert B, Slater R. Social cash transfers in low income African countries: conditional or unconditional? Development Policy Rev. 2006;24(5):571–8.CrossRef
51.
John London A, Borasky DAJ, Ghan A. Improving ethical review of research involving incentives for health promotion. PLoS Med. 2012;9(3).
52.
Wolf S, Aber JL, Morris P. Drawing on psychological theory to understand and improve antipoverty policies: the case of conditional cash transfers. Psychology Public Policy and Law. 2013;19(1):3–14.CrossRef
53.
Thornton RL. The demand for and impact of learning HIV status: evidence from field experiment 2006 [31 October 2009]
54.
55.
Robertson L, Mushati P, Eaton JW, Dumba L, Mavise G, Makoni J, et al. Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: a cluster-randomised trial. Lancet. 2013;381(9874):1283–92.CrossRefPubMedPubMedCentral
56.
Barreira D. Social protection interventions for TB control: the Brazilian experience. WHO consultation: social protecton interventions for TB control; 29 April 2013, Sao Paulo, Brazil
57.
Azevedo V, Robles M. Multidimensional Targeting: Identifying beneficiaries of conditional cash transfer programs. 2010. [03 June 2014]. Available from: http://​www.​chronicpoverty.​org/​uploads/​publication_​files/​azevedo_​robles_​multidimensional​.​pdf
58.
UK Department for International Development. DFID Cash transfers literature review. London: DFID; 2011.
59.
Gentilini U, Omamo SW. Social protection 2.0: Exploring issues, evidence and debates in a globalizing world. Food Policy. 2011;36(3):329–40.CrossRef
60.
Kim J, MacPherson E, Pronyk P, Barnett T, Watts C, Ford Foundation. Global review of good practices on the intersections between HIV/AIDS and economic empowerment. Final Report. New York: Ford Foundation; 2009.
61.
Laxminarayan R, Klein E, Dye C, Floyd K, Darley S, Adeji O. Economic benefit of tuberculosis control. Washington DC: World Bank; 2007.
62.
Verguet S, Olson ZD, Babigumira JB, Desalegn D, Johansson KA, Kruk ME, et al. Health gains and financial risk protection afforded by public financing of selected interventions in Ethiopia: an extended cost-effectiveness analysis. Lancet Glob Health. 2015;3(5):e288–96.CrossRefPubMed
63.
Grimard F, Harling G. The impact of tuberculosis on economic growth. Montréal: McGill University; 2004.
64.
Tanimura T, Jaramillo E, Weil D, Raviglione M, Lonnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014
65.
Wingfield T, Boccia D, Tovar M, Gavino A, Zevallos K, Montoya R, et al. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru. PLoS Med. 2014;11(7):e1001675.CrossRefPubMedPubMedCentral
66.
Vassall A, Remme M, Watts C, Hallett T, Siapka M, Vickerman P, et al. Financing essential HIV services: a new economic agenda. PLoS Med. 2013;10(12):e1001567.CrossRefPubMedPubMedCentral
67.
Kim J, Ferrari G, Abramsky T, Watts C, Hargreaves J, Morison L, et al. Assessing the incremental effects of combining economic and health interventions: the IMAGE study in South Africa. Bull World Health Organ. 2009;87(11):824–32.CrossRefPubMedPubMedCentral
68.
Schwartlander B, Stover J, Hallett T, Atun R, Avila C, Gouws E, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011;377(9782):2031–41.CrossRefPubMed
69.
Lonnroth K, Glaziou P, Weil D, Floyd K, Uplekar M, Raviglione M. Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention. PLoS Med. 2014;11(9):e1001693.CrossRefPubMedPubMedCentral
70.
Madan J, Lonnroth K, Laokri S, Squire SB. What can dissaving tell us about catastrophic costs? Linear and logistic regression analysis of the relationship between patient costs and financial coping strategies adopted by tuberculosis patients in Bangladesh, Tanzania and Bangalore, India. BMC Health Serv Res. 2015;15(1):476.CrossRefPubMedPubMedCentral
71.
Floyd K. Costs and effectiveness--the impact of economic studies on TB control. Tuberculosis (Edinb). 2003;83(1–3):187–200.CrossRef
72.
Floyd K, Pantoja A. Financial resources required for tuberculosis control to achieve global targets set for 2015. Bull World Health Organ. 2008;86(7):568–76.CrossRefPubMedPubMedCentral
73.
Wingfield T, Tovar MA, Huff D, Boccia D, Montoya R, Ramos E, et al. A novel socioeconomic intervention improves TB cure and chemoprophylaxis completion in Peruvian shantytowns: a randomized controlled evaluation. 46th Union Word Conference on Lung Health. Cape Town: Union/CDC Late-breaker Session on TB; 2015.
Metadata
Title
Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities
Authors
Delia Boccia
Debora Pedrazzoli
Tom Wingfield
Ernesto Jaramillo
Knut Lönnroth
James Lewis
James Hargreaves
Carlton A. Evans
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1529-8

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue

Case report

HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature

Research article

Enteropathogens in children less than 5 years of age with acute diarrhea: a 5-year surveillance study in the Southeast Coast of China

Research article

Prevalence and mortality of cancer among HIV-infected inpatients in Beijing, China

Research article

HPV Vaccine utilization, Alberta 2008/09 – 2013/14 School year

Research article

Characteristics and outcomes of cryptococcal meningitis in HIV seronegative children in Beijing, China, 2002–2013

Research article

Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits